maxgraft® cortico-cancellous granules, 1.0 cc + Hya, 0.25 mm
Botiss

34010XS

maxgraft® cortico-cancellous granules, 1.0 cc + Hya, 0.25 mm

25,900 ISKExcl. VAT

maxgraft® +HyA is an allogeneic bone graft in which cortico-cancellous granules from human donor bone are combined with hyaluronic acid. Hyaluronic acid has pronounced fluid-binding properties, so when saline is added the material can achieve a 'sticky bone'-like consistency that is easy to place and dimensionally stable during the procedure.

  • Granule size: XS, below 0.25 mm – finely ground, paste-like consistency suitable for application in narrow defects
  • Volume 1.0 cc
  • Cortico-cancellous composition provides good volume stability
  • Human allograft processed with the Allotec® process (Cells+Tissuebank Austria)

Suitable for periodontal bone defects, socket preservation and peri-implant defects as well as guided bone regeneration procedures in the aesthetic zone, where predictable volume preservation and good soft tissue integration are important.

The tissue bank requires the name of the responsible clinician and the surgery date and time when allografts are ordered.

Þarftu hjálp?

Goes well with

May be in stock - otherwise 5-10 days delivery

Questions, please call 3131 1925

Quality produced in Austria

Exclusively at Puredent

Product specifications

Granule size
0.25 mm
Quantity
1.0 cc
Application

Guided bone regeneration (GBR) and periodontology

Product Family
maxgraft® cortico-cancellous +HyA
Material
Allogeneic cortico-cancellous bone matrix with hyaluronic acid

Product details

Clinical versatility with four solutions

Pure spongy maxgraft®+HyA (small and large granules) provides a highly porous structure that supports optimal revascularization and supply of vital cells, enabling rapid regeneration of vital bone tissue.

The cortico-spongy variant (small granules), consisting of approx. 70% cortical and 30% spongy bone, offers improved volume stability. This makes it particularly suitable for guided bone regeneration in the aesthetic zone, where predictable volume preservation and integration of soft tissue are crucial.

The extra fine cortico-spongious variant (XS granules) achieves a paste-like consistency upon hydration, allowing for easy application with a conventional Luer-tip syringe – ideal for filling small or narrow defects.

Read more at botiss.com

Tissue bank CTBA

Botiss biomaterials produces its allografts in cooperation with the CTBA tissue bank in Austria. The Maxgraft® product range covers granules, bone blocks, and bone plates.

See how Maxgraft is made in the video.

Clinical cases

Find inspiration in the extensive case material at botiss.com.

See case

Clinical cases

Find inspiration in the extensive case material at botiss.com.

See case

Clinical cases

Find inspiration in the extensive case material at botiss.com.

See case

Webinars

Recorded webinars and expert talks with international clinicians on the materials on this page. See all webinars

WebinarIn English

Biofunctionalization with hyaluronic acid – impact on dental regeneration

Prof. Anton Sculean (Switzerland), Dr. Marius Steigmann (Germany), Dr. Dragana Rakasevic (Serbia), Dr. Miguel Stanley (Portugal)

Four clinicians and researchers cover hyaluronic acid in regenerative dentistry: the biological rationale and periodontal uses, cerabone® +HyA in GBR and aesthetic implant dentistry, and an ongoing clinical trial on treating peri-implantitis.

Watch at botiss (opens in a new window)

WebinarIn English

cerabone® +HyA in regenerative implantology

Dr. Andoni Jones (Ireland)

Dr. Andoni Jones shows how cerabone® +HyA is used in everyday grafting, from simple to complex cases, stressing thorough diagnosis and choosing the biomaterial each case calls for.

Watch at botiss (opens in a new window)

Expert talkIn English

Challenging autogenous bone as the Gold Standard in bone augmentation

PD Dr. Frank Kloss (Austria), Dr. Algirdas Puišys (Lithuania), Dr. Jochen Tunkel (Germany), Dr. Larissa Steigmann (Germany)

Expert panel from the bone & tissue day Singapore 2024, moderated by Dr. Larissa Steigmann. The panel discusses whether autogenous bone is still the gold standard in bone augmentation, covering block grafting, the shell technique and particulate grafting.

Watch at botiss (opens in a new window)

WebinarIn English

Indications and surgical procedures of the maxgraft® blocks and maxgraft® cortico

PD Dr. Frank Kloss (Austria)

PD Dr. Frank Kloss covers the indications and surgical technique for allogenic maxgraft® blocks and maxgraft® cortico, including the advantages over autogenous bone such as avoiding a donor site.

Watch at botiss (opens in a new window)

WebinarIn English

Innovative Clinical Solutions for Implant Cases in the Aesthetic Zone: Thinking Beyond the Conventional – Cases Discussion

Dr. Hassan Maghaireh (Bretland)

Dr. Hassan Maghaireh discusses bone-grafting cases in the aesthetic zone, both immediate and two-stage. He combines maxgraft® particles with cerabone® under a Jason® membrane and uses maxgraft® bonebuilder blocks in staged procedures.

Watch at botiss (opens in a new window)

WebinarIn Spanish with English subtitles

Management of compromised sockets using Magnesium Shield Technique

Dr. Erick Mota (Dominican Republic)

Dr. Erick Mota presents the Magnesium Shield technique with NOVAMag® for immediate implants in the anterior region when the buccal wall is missing or lost at extraction.

Watch at botiss (opens in a new window)